Spaceflight radiation carcinogenesis gamma rays that produce the same biological effect are called relative biological effectiveness (RBE) factors. The types of tumors in humans who are exposed to space radiation will be different from those who are exposed to low-LET radiation. This is evidenced by a study that observed mice with neutrons and have RBEs that vary with the tissue type and strain. The various approaches to setting acceptable levels of radiation risk are summarized below: NCRP Report No. 153 provides a more recent review of cancer and other radiation risks. This report also identifies and describes the information needed to make radiation
Radiation-induced lumbar plexopathy limiting the mean dose to < 45 Gy. One approach to reduced levels, the plexus' mapping with other organs at risk, was clinically evaluated during the 2010s. Clinical evidence of the cause-and-effect of prevention and the management of radiation induced polyneuropathy is limited. In 2011 the National Radiation Oncology Registry (NROR) was announced by the Radiation Oncology Institute (ROI). ROI and Massachusetts General Hospital would collect efficacy and side effect information (like radiation induced neuropathy) from people who had undergone radiotherapy. In 2013 the American Society for Radiation Oncology joined the effort. Experimental approaches of RILP treatment include: Radiation-induced lumbar